nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Memantine—Alzheimer's disease	0.389	0.6	CbGbCtD
Letrozole—CYP3A4—Rivastigmine—Alzheimer's disease	0.112	0.173	CbGbCtD
Letrozole—CYP3A4—Donepezil—Alzheimer's disease	0.0898	0.138	CbGbCtD
Letrozole—CYP3A4—Galantamine—Alzheimer's disease	0.0578	0.0891	CbGbCtD
Letrozole—CYP19A1—Endogenous sterols—CYP46A1—Alzheimer's disease	0.00189	0.0555	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00162	0.0478	CbGpPWpGaD
Letrozole—CYP2A6—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.0012	0.0354	CbGpPWpGaD
Letrozole—CYP19A1—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.00113	0.0331	CbGpPWpGaD
Letrozole—CYP2A6—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00111	0.0328	CbGpPWpGaD
Letrozole—CYP2A6—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000891	0.0262	CbGpPWpGaD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000876	0.0258	CbGpPWpGaD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000865	0.0255	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.000828	0.0244	CbGpPWpGaD
Letrozole—CYP2A6—Xenobiotics—CYP2D6—Alzheimer's disease	0.000745	0.0219	CbGpPWpGaD
Letrozole—CYP2A6—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000716	0.0211	CbGpPWpGaD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00071	0.0209	CbGpPWpGaD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000698	0.0205	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000688	0.0203	CbGpPWpGaD
Letrozole—Pollakiuria—Memantine—Alzheimer's disease	0.00065	0.00205	CcSEcCtD
Letrozole—CYP19A1—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000647	0.019	CbGpPWpGaD
Letrozole—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000646	0.00204	CcSEcCtD
Letrozole—Weight increased—Memantine—Alzheimer's disease	0.00064	0.00202	CcSEcCtD
Letrozole—Weight decreased—Memantine—Alzheimer's disease	0.000636	0.00201	CcSEcCtD
Letrozole—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000636	0.00201	CcSEcCtD
Letrozole—Malaise—Galantamine—Alzheimer's disease	0.000628	0.00198	CcSEcCtD
Letrozole—Infestation—Memantine—Alzheimer's disease	0.000627	0.00198	CcSEcCtD
Letrozole—Infestation NOS—Memantine—Alzheimer's disease	0.000627	0.00198	CcSEcCtD
Letrozole—Weight increased—Rivastigmine—Alzheimer's disease	0.000626	0.00198	CcSEcCtD
Letrozole—Vertigo—Galantamine—Alzheimer's disease	0.000626	0.00198	CcSEcCtD
Letrozole—Depression—Memantine—Alzheimer's disease	0.000625	0.00197	CcSEcCtD
Letrozole—Haemoglobin—Donepezil—Alzheimer's disease	0.000623	0.00197	CcSEcCtD
Letrozole—Weight decreased—Rivastigmine—Alzheimer's disease	0.000623	0.00197	CcSEcCtD
Letrozole—Hepatitis—Donepezil—Alzheimer's disease	0.00062	0.00196	CcSEcCtD
Letrozole—Haemorrhage—Donepezil—Alzheimer's disease	0.00062	0.00196	CcSEcCtD
Letrozole—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000618	0.00195	CcSEcCtD
Letrozole—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000617	0.00195	CcSEcCtD
Letrozole—Palpitations—Galantamine—Alzheimer's disease	0.000616	0.00194	CcSEcCtD
Letrozole—Myocardial infarction—Memantine—Alzheimer's disease	0.000615	0.00194	CcSEcCtD
Letrozole—Infestation—Rivastigmine—Alzheimer's disease	0.000614	0.00194	CcSEcCtD
Letrozole—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000614	0.00194	CcSEcCtD
Letrozole—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000612	0.00193	CcSEcCtD
Letrozole—Depression—Rivastigmine—Alzheimer's disease	0.000612	0.00193	CcSEcCtD
Letrozole—Oedema peripheral—Donepezil—Alzheimer's disease	0.000611	0.00193	CcSEcCtD
Letrozole—Urinary tract infection—Memantine—Alzheimer's disease	0.00061	0.00192	CcSEcCtD
Letrozole—Urethral disorder—Donepezil—Alzheimer's disease	0.000608	0.00192	CcSEcCtD
Letrozole—Cough—Galantamine—Alzheimer's disease	0.000608	0.00192	CcSEcCtD
Letrozole—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000605	0.00191	CcSEcCtD
Letrozole—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000602	0.0019	CcSEcCtD
Letrozole—Hypertension—Galantamine—Alzheimer's disease	0.000601	0.0019	CcSEcCtD
Letrozole—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000596	0.00188	CcSEcCtD
Letrozole—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000593	0.00187	CcSEcCtD
Letrozole—Chest pain—Galantamine—Alzheimer's disease	0.000593	0.00187	CcSEcCtD
Letrozole—Arthralgia—Galantamine—Alzheimer's disease	0.000593	0.00187	CcSEcCtD
Letrozole—Myalgia—Galantamine—Alzheimer's disease	0.000593	0.00187	CcSEcCtD
Letrozole—Anxiety—Galantamine—Alzheimer's disease	0.000591	0.00187	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000589	0.00186	CcSEcCtD
Letrozole—Sweating—Rivastigmine—Alzheimer's disease	0.000588	0.00186	CcSEcCtD
Letrozole—Discomfort—Galantamine—Alzheimer's disease	0.000586	0.00185	CcSEcCtD
Letrozole—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00058	0.00183	CcSEcCtD
Letrozole—Dry mouth—Galantamine—Alzheimer's disease	0.00058	0.00183	CcSEcCtD
Letrozole—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.000568	0.0167	CbGpPWpGaD
Letrozole—Haemoglobin—Memantine—Alzheimer's disease	0.000566	0.00179	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000565	0.0166	CbGpPWpGaD
Letrozole—Haemorrhage—Memantine—Alzheimer's disease	0.000563	0.00178	CcSEcCtD
Letrozole—Hepatitis—Memantine—Alzheimer's disease	0.000563	0.00178	CcSEcCtD
Letrozole—Hypoaesthesia—Memantine—Alzheimer's disease	0.00056	0.00177	CcSEcCtD
Letrozole—Nervous system disorder—Galantamine—Alzheimer's disease	0.000558	0.00176	CcSEcCtD
Letrozole—Urinary tract disorder—Memantine—Alzheimer's disease	0.000556	0.00176	CcSEcCtD
Letrozole—Tachycardia—Galantamine—Alzheimer's disease	0.000555	0.00175	CcSEcCtD
Letrozole—Oedema peripheral—Memantine—Alzheimer's disease	0.000555	0.00175	CcSEcCtD
Letrozole—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000554	0.00175	CcSEcCtD
Letrozole—Connective tissue disorder—Memantine—Alzheimer's disease	0.000553	0.00175	CcSEcCtD
Letrozole—Skin disorder—Galantamine—Alzheimer's disease	0.000552	0.00174	CcSEcCtD
Letrozole—Urethral disorder—Memantine—Alzheimer's disease	0.000552	0.00174	CcSEcCtD
Letrozole—Hepatitis—Rivastigmine—Alzheimer's disease	0.000551	0.00174	CcSEcCtD
Letrozole—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000551	0.00174	CcSEcCtD
Letrozole—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00055	0.00173	CcSEcCtD
Letrozole—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000548	0.00173	CcSEcCtD
Letrozole—Alopecia—Donepezil—Alzheimer's disease	0.000548	0.00173	CcSEcCtD
Letrozole—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000544	0.00172	CcSEcCtD
Letrozole—Mental disorder—Donepezil—Alzheimer's disease	0.000543	0.00171	CcSEcCtD
Letrozole—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000543	0.00171	CcSEcCtD
Letrozole—Anorexia—Galantamine—Alzheimer's disease	0.000542	0.00171	CcSEcCtD
Letrozole—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000541	0.00171	CcSEcCtD
Letrozole—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00054	0.0017	CcSEcCtD
Letrozole—Malnutrition—Donepezil—Alzheimer's disease	0.00054	0.0017	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—BDNF—Alzheimer's disease	0.000534	0.0157	CbGpPWpGaD
Letrozole—Erythema multiforme—Memantine—Alzheimer's disease	0.000532	0.00168	CcSEcCtD
Letrozole—Tension—Donepezil—Alzheimer's disease	0.00053	0.00167	CcSEcCtD
Letrozole—Dysgeusia—Donepezil—Alzheimer's disease	0.000529	0.00167	CcSEcCtD
Letrozole—Eye disorder—Memantine—Alzheimer's disease	0.000526	0.00166	CcSEcCtD
Letrozole—Nervousness—Donepezil—Alzheimer's disease	0.000524	0.00165	CcSEcCtD
Letrozole—Cardiac disorder—Memantine—Alzheimer's disease	0.000523	0.00165	CcSEcCtD
Letrozole—Flushing—Memantine—Alzheimer's disease	0.000523	0.00165	CcSEcCtD
Letrozole—Back pain—Donepezil—Alzheimer's disease	0.000522	0.00165	CcSEcCtD
Letrozole—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000521	0.00164	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000518	0.00163	CcSEcCtD
Letrozole—Eye disorder—Rivastigmine—Alzheimer's disease	0.000515	0.00162	CcSEcCtD
Letrozole—Insomnia—Galantamine—Alzheimer's disease	0.000514	0.00162	CcSEcCtD
Letrozole—Flushing—Rivastigmine—Alzheimer's disease	0.000511	0.00161	CcSEcCtD
Letrozole—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000511	0.00161	CcSEcCtD
Letrozole—Angiopathy—Memantine—Alzheimer's disease	0.000511	0.00161	CcSEcCtD
Letrozole—Paraesthesia—Galantamine—Alzheimer's disease	0.000511	0.00161	CcSEcCtD
Letrozole—Vision blurred—Donepezil—Alzheimer's disease	0.000509	0.00161	CcSEcCtD
Letrozole—Mediastinal disorder—Memantine—Alzheimer's disease	0.000508	0.0016	CcSEcCtD
Letrozole—Somnolence—Galantamine—Alzheimer's disease	0.000505	0.0016	CcSEcCtD
Letrozole—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000501	0.00158	CcSEcCtD
Letrozole—Dyspepsia—Galantamine—Alzheimer's disease	0.0005	0.00158	CcSEcCtD
Letrozole—Angiopathy—Rivastigmine—Alzheimer's disease	0.0005	0.00158	CcSEcCtD
Letrozole—Alopecia—Memantine—Alzheimer's disease	0.000498	0.00157	CcSEcCtD
Letrozole—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000496	0.00157	CcSEcCtD
Letrozole—Decreased appetite—Galantamine—Alzheimer's disease	0.000494	0.00156	CcSEcCtD
Letrozole—Mental disorder—Memantine—Alzheimer's disease	0.000493	0.00156	CcSEcCtD
Letrozole—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000491	0.00155	CcSEcCtD
Letrozole—Malnutrition—Memantine—Alzheimer's disease	0.00049	0.00155	CcSEcCtD
Letrozole—Fatigue—Galantamine—Alzheimer's disease	0.00049	0.00155	CcSEcCtD
Letrozole—Malaise—Donepezil—Alzheimer's disease	0.000487	0.00154	CcSEcCtD
Letrozole—Alopecia—Rivastigmine—Alzheimer's disease	0.000487	0.00154	CcSEcCtD
Letrozole—Constipation—Galantamine—Alzheimer's disease	0.000486	0.00153	CcSEcCtD
Letrozole—Vertigo—Donepezil—Alzheimer's disease	0.000485	0.00153	CcSEcCtD
Letrozole—Mental disorder—Rivastigmine—Alzheimer's disease	0.000483	0.00152	CcSEcCtD
Letrozole—Tension—Memantine—Alzheimer's disease	0.000481	0.00152	CcSEcCtD
Letrozole—Dysgeusia—Memantine—Alzheimer's disease	0.00048	0.00152	CcSEcCtD
Letrozole—Malnutrition—Rivastigmine—Alzheimer's disease	0.00048	0.00151	CcSEcCtD
Letrozole—Nervousness—Memantine—Alzheimer's disease	0.000476	0.0015	CcSEcCtD
Letrozole—Back pain—Memantine—Alzheimer's disease	0.000474	0.0015	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000474	0.014	CbGpPWpGaD
Letrozole—Cough—Donepezil—Alzheimer's disease	0.000471	0.00149	CcSEcCtD
Letrozole—Tension—Rivastigmine—Alzheimer's disease	0.000471	0.00149	CcSEcCtD
Letrozole—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00047	0.00148	CcSEcCtD
Letrozole—Feeling abnormal—Galantamine—Alzheimer's disease	0.000469	0.00148	CcSEcCtD
Letrozole—Hypertension—Donepezil—Alzheimer's disease	0.000466	0.00147	CcSEcCtD
Letrozole—Nervousness—Rivastigmine—Alzheimer's disease	0.000466	0.00147	CcSEcCtD
Letrozole—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000465	0.00147	CcSEcCtD
Letrozole—Back pain—Rivastigmine—Alzheimer's disease	0.000464	0.00146	CcSEcCtD
Letrozole—Vision blurred—Memantine—Alzheimer's disease	0.000462	0.00146	CcSEcCtD
Letrozole—Chest pain—Donepezil—Alzheimer's disease	0.00046	0.00145	CcSEcCtD
Letrozole—Myalgia—Donepezil—Alzheimer's disease	0.00046	0.00145	CcSEcCtD
Letrozole—Arthralgia—Donepezil—Alzheimer's disease	0.00046	0.00145	CcSEcCtD
Letrozole—Anxiety—Donepezil—Alzheimer's disease	0.000458	0.00145	CcSEcCtD
Letrozole—Ill-defined disorder—Memantine—Alzheimer's disease	0.000455	0.00144	CcSEcCtD
Letrozole—Discomfort—Donepezil—Alzheimer's disease	0.000454	0.00143	CcSEcCtD
Letrozole—Vision blurred—Rivastigmine—Alzheimer's disease	0.000452	0.00143	CcSEcCtD
Letrozole—Dry mouth—Donepezil—Alzheimer's disease	0.00045	0.00142	CcSEcCtD
Letrozole—Body temperature increased—Galantamine—Alzheimer's disease	0.000449	0.00142	CcSEcCtD
Letrozole—Abdominal pain—Galantamine—Alzheimer's disease	0.000449	0.00142	CcSEcCtD
Letrozole—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000445	0.0014	CcSEcCtD
Letrozole—Malaise—Memantine—Alzheimer's disease	0.000442	0.0014	CcSEcCtD
Letrozole—Oedema—Donepezil—Alzheimer's disease	0.000441	0.00139	CcSEcCtD
Letrozole—Vertigo—Memantine—Alzheimer's disease	0.00044	0.00139	CcSEcCtD
Letrozole—Leukopenia—Memantine—Alzheimer's disease	0.000439	0.00138	CcSEcCtD
Letrozole—Infection—Donepezil—Alzheimer's disease	0.000438	0.00138	CcSEcCtD
Letrozole—CYP2A6—Fluoropyrimidine Activity—SMUG1—Alzheimer's disease	0.000437	0.0129	CbGpPWpGaD
Letrozole—Palpitations—Memantine—Alzheimer's disease	0.000433	0.00137	CcSEcCtD
Letrozole—Malaise—Rivastigmine—Alzheimer's disease	0.000432	0.00136	CcSEcCtD
Letrozole—Nervous system disorder—Donepezil—Alzheimer's disease	0.000432	0.00136	CcSEcCtD
Letrozole—Vertigo—Rivastigmine—Alzheimer's disease	0.000431	0.00136	CcSEcCtD
Letrozole—Cough—Memantine—Alzheimer's disease	0.000428	0.00135	CcSEcCtD
Letrozole—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000426	0.00134	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000424	0.0125	CbGpPWpGaD
Letrozole—Palpitations—Rivastigmine—Alzheimer's disease	0.000424	0.00134	CcSEcCtD
Letrozole—Hypertension—Memantine—Alzheimer's disease	0.000423	0.00134	CcSEcCtD
Letrozole—Anorexia—Donepezil—Alzheimer's disease	0.00042	0.00133	CcSEcCtD
Letrozole—Cough—Rivastigmine—Alzheimer's disease	0.000418	0.00132	CcSEcCtD
Letrozole—Myalgia—Memantine—Alzheimer's disease	0.000417	0.00132	CcSEcCtD
Letrozole—Chest pain—Memantine—Alzheimer's disease	0.000417	0.00132	CcSEcCtD
Letrozole—Arthralgia—Memantine—Alzheimer's disease	0.000417	0.00132	CcSEcCtD
Letrozole—Anxiety—Memantine—Alzheimer's disease	0.000416	0.00131	CcSEcCtD
Letrozole—Hypertension—Rivastigmine—Alzheimer's disease	0.000414	0.00131	CcSEcCtD
Letrozole—Discomfort—Memantine—Alzheimer's disease	0.000412	0.0013	CcSEcCtD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000408	0.012	CbGpPWpGaD
Letrozole—Myalgia—Rivastigmine—Alzheimer's disease	0.000408	0.00129	CcSEcCtD
Letrozole—Arthralgia—Rivastigmine—Alzheimer's disease	0.000408	0.00129	CcSEcCtD
Letrozole—Chest pain—Rivastigmine—Alzheimer's disease	0.000408	0.00129	CcSEcCtD
Letrozole—Dry mouth—Memantine—Alzheimer's disease	0.000408	0.00129	CcSEcCtD
Letrozole—Asthenia—Galantamine—Alzheimer's disease	0.000408	0.00129	CcSEcCtD
Letrozole—Anxiety—Rivastigmine—Alzheimer's disease	0.000407	0.00128	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000405	0.00128	CcSEcCtD
Letrozole—Discomfort—Rivastigmine—Alzheimer's disease	0.000403	0.00127	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000401	0.00127	CcSEcCtD
Letrozole—Oedema—Memantine—Alzheimer's disease	0.0004	0.00126	CcSEcCtD
Letrozole—Dry mouth—Rivastigmine—Alzheimer's disease	0.000399	0.00126	CcSEcCtD
Letrozole—Insomnia—Donepezil—Alzheimer's disease	0.000399	0.00126	CcSEcCtD
Letrozole—Infection—Memantine—Alzheimer's disease	0.000397	0.00125	CcSEcCtD
Letrozole—Paraesthesia—Donepezil—Alzheimer's disease	0.000396	0.00125	CcSEcCtD
Letrozole—Dyspnoea—Donepezil—Alzheimer's disease	0.000393	0.00124	CcSEcCtD
Letrozole—Nervous system disorder—Memantine—Alzheimer's disease	0.000392	0.00124	CcSEcCtD
Letrozole—Somnolence—Donepezil—Alzheimer's disease	0.000392	0.00124	CcSEcCtD
Letrozole—Oedema—Rivastigmine—Alzheimer's disease	0.000391	0.00124	CcSEcCtD
Letrozole—Tachycardia—Memantine—Alzheimer's disease	0.00039	0.00123	CcSEcCtD
Letrozole—Diarrhoea—Galantamine—Alzheimer's disease	0.000389	0.00123	CcSEcCtD
Letrozole—Infection—Rivastigmine—Alzheimer's disease	0.000389	0.00123	CcSEcCtD
Letrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000389	0.0114	CbGpPWpGaD
Letrozole—Skin disorder—Memantine—Alzheimer's disease	0.000389	0.00123	CcSEcCtD
Letrozole—Dyspepsia—Donepezil—Alzheimer's disease	0.000388	0.00122	CcSEcCtD
Letrozole—Hyperhidrosis—Memantine—Alzheimer's disease	0.000387	0.00122	CcSEcCtD
Letrozole—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000384	0.00121	CcSEcCtD
Letrozole—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000384	0.0113	CbGpPWpGaD
Letrozole—Decreased appetite—Donepezil—Alzheimer's disease	0.000383	0.00121	CcSEcCtD
Letrozole—CYP2A6—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000382	0.0112	CbGpPWpGaD
Letrozole—Tachycardia—Rivastigmine—Alzheimer's disease	0.000382	0.00121	CcSEcCtD
Letrozole—Anorexia—Memantine—Alzheimer's disease	0.000381	0.0012	CcSEcCtD
Letrozole—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00038	0.0012	CcSEcCtD
Letrozole—Skin disorder—Rivastigmine—Alzheimer's disease	0.00038	0.0012	CcSEcCtD
Letrozole—Fatigue—Donepezil—Alzheimer's disease	0.00038	0.0012	CcSEcCtD
Letrozole—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000378	0.00119	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000377	0.0111	CbGpPWpGaD
Letrozole—Pain—Donepezil—Alzheimer's disease	0.000377	0.00119	CcSEcCtD
Letrozole—Constipation—Donepezil—Alzheimer's disease	0.000377	0.00119	CcSEcCtD
Letrozole—Dizziness—Galantamine—Alzheimer's disease	0.000376	0.00119	CcSEcCtD
Letrozole—Anorexia—Rivastigmine—Alzheimer's disease	0.000373	0.00118	CcSEcCtD
Letrozole—CYP19A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000372	0.011	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000364	0.00115	CcSEcCtD
Letrozole—Feeling abnormal—Donepezil—Alzheimer's disease	0.000363	0.00115	CcSEcCtD
Letrozole—Insomnia—Memantine—Alzheimer's disease	0.000362	0.00114	CcSEcCtD
Letrozole—Vomiting—Galantamine—Alzheimer's disease	0.000361	0.00114	CcSEcCtD
Letrozole—CYP19A1—FSH signaling pathway—CREB1—Alzheimer's disease	0.000361	0.0106	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00036	0.00114	CcSEcCtD
Letrozole—Paraesthesia—Memantine—Alzheimer's disease	0.000359	0.00113	CcSEcCtD
Letrozole—Rash—Galantamine—Alzheimer's disease	0.000358	0.00113	CcSEcCtD
Letrozole—Dermatitis—Galantamine—Alzheimer's disease	0.000358	0.00113	CcSEcCtD
Letrozole—Dyspnoea—Memantine—Alzheimer's disease	0.000357	0.00113	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000357	0.00113	CcSEcCtD
Letrozole—Headache—Galantamine—Alzheimer's disease	0.000356	0.00112	CcSEcCtD
Letrozole—Somnolence—Memantine—Alzheimer's disease	0.000356	0.00112	CcSEcCtD
Letrozole—Insomnia—Rivastigmine—Alzheimer's disease	0.000354	0.00112	CcSEcCtD
Letrozole—Dyspepsia—Memantine—Alzheimer's disease	0.000352	0.00111	CcSEcCtD
Letrozole—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000351	0.00111	CcSEcCtD
Letrozole—Urticaria—Donepezil—Alzheimer's disease	0.00035	0.0011	CcSEcCtD
Letrozole—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000349	0.0011	CcSEcCtD
Letrozole—Abdominal pain—Donepezil—Alzheimer's disease	0.000348	0.0011	CcSEcCtD
Letrozole—Body temperature increased—Donepezil—Alzheimer's disease	0.000348	0.0011	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Alzheimer's disease	0.000348	0.0102	CbGpPWpGaD
Letrozole—Somnolence—Rivastigmine—Alzheimer's disease	0.000348	0.0011	CcSEcCtD
Letrozole—Decreased appetite—Memantine—Alzheimer's disease	0.000348	0.0011	CcSEcCtD
Letrozole—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000345	0.00109	CcSEcCtD
Letrozole—Fatigue—Memantine—Alzheimer's disease	0.000345	0.00109	CcSEcCtD
Letrozole—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000345	0.00109	CcSEcCtD
Letrozole—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000344	0.0101	CbGpPWpGaD
Letrozole—Pain—Memantine—Alzheimer's disease	0.000342	0.00108	CcSEcCtD
Letrozole—Constipation—Memantine—Alzheimer's disease	0.000342	0.00108	CcSEcCtD
Letrozole—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00034	0.00107	CcSEcCtD
Letrozole—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000338	0.00107	CcSEcCtD
Letrozole—Nausea—Galantamine—Alzheimer's disease	0.000338	0.00107	CcSEcCtD
Letrozole—Fatigue—Rivastigmine—Alzheimer's disease	0.000337	0.00106	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000337	0.00993	CbGpPWpGaD
Letrozole—Pain—Rivastigmine—Alzheimer's disease	0.000335	0.00106	CcSEcCtD
Letrozole—Constipation—Rivastigmine—Alzheimer's disease	0.000335	0.00106	CcSEcCtD
Letrozole—Feeling abnormal—Memantine—Alzheimer's disease	0.00033	0.00104	CcSEcCtD
Letrozole—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000329	0.00967	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000327	0.00103	CcSEcCtD
Letrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000326	0.00961	CbGpPWpGaD
Letrozole—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000323	0.00102	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000321	0.00946	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00032	0.00101	CcSEcCtD
Letrozole—Urticaria—Memantine—Alzheimer's disease	0.000318	0.001	CcSEcCtD
Letrozole—Body temperature increased—Memantine—Alzheimer's disease	0.000316	0.000998	CcSEcCtD
Letrozole—Abdominal pain—Memantine—Alzheimer's disease	0.000316	0.000998	CcSEcCtD
Letrozole—Asthenia—Donepezil—Alzheimer's disease	0.000316	0.000998	CcSEcCtD
Letrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000315	0.00927	CbGpPWpGaD
Letrozole—Pruritus—Donepezil—Alzheimer's disease	0.000312	0.000984	CcSEcCtD
Letrozole—Urticaria—Rivastigmine—Alzheimer's disease	0.000311	0.000981	CcSEcCtD
Letrozole—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000309	0.000976	CcSEcCtD
Letrozole—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000309	0.000976	CcSEcCtD
Letrozole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000309	0.0091	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—MTHFR—Alzheimer's disease	0.000306	0.009	CbGpPWpGaD
Letrozole—CYP2A6—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000305	0.00898	CbGpPWpGaD
Letrozole—Diarrhoea—Donepezil—Alzheimer's disease	0.000301	0.000951	CcSEcCtD
Letrozole—CYP2A6—Biological oxidations—CYP46A1—Alzheimer's disease	0.0003	0.00884	CbGpPWpGaD
Letrozole—Dizziness—Donepezil—Alzheimer's disease	0.000291	0.00092	CcSEcCtD
Letrozole—Asthenia—Memantine—Alzheimer's disease	0.000287	0.000906	CcSEcCtD
Letrozole—Pruritus—Memantine—Alzheimer's disease	0.000283	0.000893	CcSEcCtD
Letrozole—Asthenia—Rivastigmine—Alzheimer's disease	0.000281	0.000886	CcSEcCtD
Letrozole—Vomiting—Donepezil—Alzheimer's disease	0.00028	0.000884	CcSEcCtD
Letrozole—Rash—Donepezil—Alzheimer's disease	0.000278	0.000877	CcSEcCtD
Letrozole—Dermatitis—Donepezil—Alzheimer's disease	0.000278	0.000876	CcSEcCtD
Letrozole—Pruritus—Rivastigmine—Alzheimer's disease	0.000277	0.000874	CcSEcCtD
Letrozole—Headache—Donepezil—Alzheimer's disease	0.000276	0.000871	CcSEcCtD
Letrozole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Alzheimer's disease	0.000274	0.00807	CbGpPWpGaD
Letrozole—Diarrhoea—Memantine—Alzheimer's disease	0.000274	0.000864	CcSEcCtD
Letrozole—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000273	0.00804	CbGpPWpGaD
Letrozole—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000268	0.000845	CcSEcCtD
Letrozole—Dizziness—Memantine—Alzheimer's disease	0.000265	0.000835	CcSEcCtD
Letrozole—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000263	0.00773	CbGpPWpGaD
Letrozole—Nausea—Donepezil—Alzheimer's disease	0.000262	0.000826	CcSEcCtD
Letrozole—Dizziness—Rivastigmine—Alzheimer's disease	0.000259	0.000817	CcSEcCtD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000256	0.00753	CbGpPWpGaD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000256	0.00753	CbGpPWpGaD
Letrozole—Vomiting—Memantine—Alzheimer's disease	0.000254	0.000803	CcSEcCtD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000252	0.00743	CbGpPWpGaD
Letrozole—Rash—Memantine—Alzheimer's disease	0.000252	0.000796	CcSEcCtD
Letrozole—Dermatitis—Memantine—Alzheimer's disease	0.000252	0.000795	CcSEcCtD
Letrozole—CYP2A6—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000251	0.00738	CbGpPWpGaD
Letrozole—Headache—Memantine—Alzheimer's disease	0.000251	0.000791	CcSEcCtD
Letrozole—Vomiting—Rivastigmine—Alzheimer's disease	0.000249	0.000785	CcSEcCtD
Letrozole—Rash—Rivastigmine—Alzheimer's disease	0.000247	0.000779	CcSEcCtD
Letrozole—Dermatitis—Rivastigmine—Alzheimer's disease	0.000247	0.000778	CcSEcCtD
Letrozole—Headache—Rivastigmine—Alzheimer's disease	0.000245	0.000774	CcSEcCtD
Letrozole—Nausea—Memantine—Alzheimer's disease	0.000238	0.00075	CcSEcCtD
Letrozole—Nausea—Rivastigmine—Alzheimer's disease	0.000232	0.000734	CcSEcCtD
Letrozole—CYP19A1—Biological oxidations—MAOB—Alzheimer's disease	0.000225	0.00663	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000217	0.00639	CbGpPWpGaD
Letrozole—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000213	0.00626	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000207	0.0061	CbGpPWpGaD
Letrozole—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000189	0.00555	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—MAOB—Alzheimer's disease	0.000179	0.00527	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000179	0.00527	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—PTGS1—Alzheimer's disease	0.000171	0.00502	CbGpPWpGaD
Letrozole—CYP19A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000167	0.00493	CbGpPWpGaD
Letrozole—CYP19A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000165	0.00486	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000157	0.00462	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000155	0.00456	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000152	0.00447	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000145	0.00427	CbGpPWpGaD
Letrozole—CYP19A1—FSH signaling pathway—AKT1—Alzheimer's disease	0.000145	0.00426	CbGpPWpGaD
Letrozole—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00014	0.00412	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—PTGS1—Alzheimer's disease	0.000136	0.004	CbGpPWpGaD
Letrozole—CYP2A6—Biological oxidations—CYP2D6—Alzheimer's disease	0.000133	0.00392	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000125	0.00369	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000124	0.00364	CbGpPWpGaD
Letrozole—CYP2A6—Fluoropyrimidine Activity—TP53—Alzheimer's disease	0.000116	0.00342	CbGpPWpGaD
Letrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000113	0.00334	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—HMOX1—Alzheimer's disease	0.000113	0.00332	CbGpPWpGaD
Letrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000112	0.00329	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.00011	0.00324	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000109	0.0032	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—AGER—Alzheimer's disease	0.000102	0.00299	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000101	0.00298	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—DHCR24—Alzheimer's disease	9.67e-05	0.00285	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	9.37e-05	0.00276	CbGpPWpGaD
Letrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	9.19e-05	0.00271	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	9.1e-05	0.00268	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	9.02e-05	0.00265	CbGpPWpGaD
Letrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	8.87e-05	0.00261	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CA4—Alzheimer's disease	8.22e-05	0.00242	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	8.04e-05	0.00237	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GAPDHS—Alzheimer's disease	7.73e-05	0.00228	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—DHCR24—Alzheimer's disease	7.7e-05	0.00227	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	7.64e-05	0.00225	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	7.33e-05	0.00216	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLD3—Alzheimer's disease	6.99e-05	0.00206	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.99e-05	0.00206	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.91e-05	0.00203	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	6.74e-05	0.00198	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	6.7e-05	0.00197	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.57e-05	0.00193	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.55e-05	0.00193	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CA4—Alzheimer's disease	6.55e-05	0.00193	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	6.45e-05	0.0019	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ND1—Alzheimer's disease	6.23e-05	0.00183	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GAPDHS—Alzheimer's disease	6.15e-05	0.00181	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.09e-05	0.00179	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ATP5A1—Alzheimer's disease	5.83e-05	0.00172	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	5.72e-05	0.00168	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.57e-05	0.00164	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLD3—Alzheimer's disease	5.57e-05	0.00164	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSD17B10—Alzheimer's disease	5.34e-05	0.00157	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP46A1—Alzheimer's disease	5.14e-05	0.00151	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.98e-05	0.00147	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ND1—Alzheimer's disease	4.96e-05	0.00146	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.88e-05	0.00144	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.82e-05	0.00142	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.8e-05	0.00141	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.37e-05	0.00129	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	4.32e-05	0.00127	CbGpPWpGaD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—Alzheimer's disease	4.29e-05	0.00126	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CHAT—Alzheimer's disease	4.02e-05	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TPI1—Alzheimer's disease	4.02e-05	0.00118	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MAOB—Alzheimer's disease	3.85e-05	0.00113	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	3.71e-05	0.00109	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.66e-05	0.00108	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.65e-05	0.00107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.63e-05	0.00107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—A2M—Alzheimer's disease	3.58e-05	0.00105	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CHAT—Alzheimer's disease	3.2e-05	0.000941	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TPI1—Alzheimer's disease	3.2e-05	0.000941	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.19e-05	0.00094	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ACHE—Alzheimer's disease	3.11e-05	0.000917	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	3.08e-05	0.000906	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MAOB—Alzheimer's disease	3.06e-05	0.000902	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	2.95e-05	0.000868	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	2.92e-05	0.000859	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ENO1—Alzheimer's disease	2.92e-05	0.000859	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	2.86e-05	0.000842	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—A2M—Alzheimer's disease	2.85e-05	0.000839	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.82e-05	0.000831	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.71e-05	0.000799	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.56e-05	0.000753	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.51e-05	0.000739	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.48e-05	0.00073	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACHE—Alzheimer's disease	2.48e-05	0.00073	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	2.45e-05	0.000721	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.4e-05	0.000706	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENO1—Alzheimer's disease	2.32e-05	0.000684	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	2.32e-05	0.000684	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	2.28e-05	0.00067	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.26e-05	0.000664	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCHE—Alzheimer's disease	2.16e-05	0.000636	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.14e-05	0.00063	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	2.14e-05	0.000629	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	2.13e-05	0.000627	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.04e-05	0.000601	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	2.04e-05	0.0006	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.98e-05	0.000581	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.96e-05	0.000576	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.95e-05	0.000573	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.88e-05	0.000554	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.82e-05	0.000535	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.75e-05	0.000516	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	1.7e-05	0.000501	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	1.69e-05	0.000499	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.64e-05	0.000482	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.63e-05	0.00048	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.62e-05	0.000476	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LPL—Alzheimer's disease	1.55e-05	0.000456	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.42e-05	0.000418	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	1.4e-05	0.000411	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—INS—Alzheimer's disease	1.39e-05	0.00041	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CALM1—Alzheimer's disease	1.3e-05	0.000384	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—APOE—Alzheimer's disease	1.3e-05	0.000382	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAV1—Alzheimer's disease	1.29e-05	0.000379	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.22e-05	0.00036	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.17e-05	0.000345	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.17e-05	0.000345	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PPARG—Alzheimer's disease	1.13e-05	0.000333	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.12e-05	0.000331	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	1.12e-05	0.000329	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—INS—Alzheimer's disease	1.11e-05	0.000327	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	0.000318	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.04e-05	0.000307	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—Alzheimer's disease	9.73e-06	0.000286	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACHE—Alzheimer's disease	9.09e-06	0.000267	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.98e-06	0.000264	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	8.9e-06	0.000262	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8.52e-06	0.000251	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8.52e-06	0.000251	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	8.35e-06	0.000246	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.92e-06	0.000233	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.47e-06	0.00022	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	7.24e-06	0.000213	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	6.24e-06	0.000184	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	6.21e-06	0.000183	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.68e-06	0.000167	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—Alzheimer's disease	5.62e-06	0.000165	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	5.12e-06	0.000151	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.78e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.76e-06	0.00014	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.72e-06	0.000139	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—Alzheimer's disease	4.47e-06	0.000132	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARG—Alzheimer's disease	4.15e-06	0.000122	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—INS—Alzheimer's disease	4.07e-06	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.57e-06	0.000105	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.26e-06	9.61e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.64e-06	4.83e-05	CbGpPWpGaD
